Clinical trial · Observational
Nutritional Status in Children With ALL in Guatemala
Nutritional Status in Children With Acute Lymphoblastic Leukemia (ALL) Undergoing Treatment at the National Pediatric Oncology Unit in Guatemala City, Guatemala
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study proposes to investigate the association of nutritional status of a children assessed by body mass index (BMI), triceps skinfold thickness (TSFT), and mid upper arm circumference (MUAC), with body composition, measured by dual-energy X-ray absorptiometry (DEXA), in 60 children undergoing treatment of ALL at Unidad Nacional de Oncologia Pediatrica (UNOP), in Guatemala City, Guatemala. The study also aims to establish normative values of body composition in children residing in an LMIC by examining 160 healthy siblings of children under treatment, and to measure habitual physical activity in children with acute lymphoblastic leukemia (ALL) at diagnosis and during therapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Children with ALL
- description
- Children undergoing ALL treatment at UNOP Guatemala who are under the age of 18 years.
- label
- Healthy siblings
- description
- Healthy siblings of children undergoing ALL treatment at UNOP Guatemala who are under the age of 18 years.
Primary outcomes (3)
- measure
- Association of BMI and Body Composition
- timeFrame
- Up to 6 months after treatment
- description
- Body composition will be measured by DEXA.
- measure
- Association of TSFT and Body Composition
- timeFrame
- Up to 6 months after treatment
- description
- Body composition will be measured by DEXA.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Children under treatment for Acute Lymphoblastic Leukemia (ALL) * Age under 18 years * Getting treatment at UNOP Exclusion Criteria: * If they can't participate in the study due to illness or long distance to travel to UNOP
References
Publications (0)
Data not yet available